Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

被引：0
|
作者：
Robert J. Noveck
Richard A. Preston
Suzanne K. Swan
机构：
[1] MDS Pharma Services,
[2] University of Miami,undefined
[3] Hennepin County Medical Center and Davita Clinical Research,undefined
来源：
Clinical Pharmacokinetics | 2007年 / 46卷
关键词：
Renal Impairment; Allergic Rhinitis; Normal Renal Function; Severe Renal Impairment; Ebastine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 534
页数：9
相关论文
共 50 条
  • [1] Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment
    Noveck, Robert J.
    Preston, Richard A.
    Swan, Suzanne K.
    CLINICAL PHARMACOKINETICS, 2007, 46 (06) : 525 - 534
  • [2] Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects
    Tammara, Brinda
    Ryan, Kelly
    Plotka, Anna
    Shafer, Frank E.
    Wei, Hua
    Readett, David
    Fang, Annie
    Korth-Bradley, Joan
    BLOOD, 2018, 132
  • [3] PHARMACOKINETICS OF CEFTAZIDIME IN HEALTHY-SUBJECTS AND IN PATIENTS WITH RENAL IMPAIRMENT
    LEROY, A
    FILLASTRE, JP
    HUMBERT, G
    BORSA, F
    LEGUY, F
    SPENCER, GR
    PRESSE MEDICALE, 1988, 17 (37): : 1917 - 1920
  • [4] PHARMACOKINETICS OF CEFPROZIL IN HEALTHY-SUBJECTS AND PATIENTS WITH RENAL IMPAIRMENT
    SHYU, WC
    PITTMAN, KA
    WILBER, RB
    MATZKE, GR
    BARBHAIYA, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04): : 362 - 371
  • [5] Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects
    O'Donnell, John
    Preston, Richard A.
    Mamikonyan, Grigor
    Stone, Emily
    Isaacs, Robin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [6] PHARMACOKINETICS OF OFLOXACIN IN HEALTHY-SUBJECTS AND PATIENTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    FLOR, S
    GUAY, D
    OPSAHL, J
    TACK, K
    MATZKE, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1991, 11 (03) : 115 - 121
  • [7] Fesoterodine pharmacokinetics in subjects with renal impairment vs. healthy subjects
    Malhotra, Bimal
    Wood, Nolan
    Guna, Zhonghong
    Gandelman, Kuan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 998 - 998
  • [8] The pharmacokinetics and safety of darapladib in subjects with severe renal impairment
    Magee, Mindy He
    Shaddinger, Bonnie
    Collins, David
    Siddiqi, Shabana
    Soffer, Joseph
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 654 - 661
  • [9] The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
    F. Jin
    M. Robeson
    H. Zhou
    G. Hisoire
    S. Ramanathan
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1133 - 1141
  • [10] The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
    Jin, Feng
    Robeson, Michelle
    Zhou, Huafeng
    Hisoire, Grace
    Ramanathan, Srini
    CANCER RESEARCH, 2014, 74 (19)
12345